|
R&D Systems
anti goat gal3 antibody Anti Goat Gal3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Human+Galectin-3+Antibody/bio_rxiv__477927-280-26-30 Average 93 stars, based on 1 article reviews
anti goat gal3 antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant mouse gal3 ![]() Recombinant Mouse Gal3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Recombinant+Mouse+Galectin-3+Protein/pmc06397689-30-14-17 Average 93 stars, based on 1 article reviews
recombinant mouse gal3 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant gal 3 ![]() Recombinant Gal 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Recombinant+Mouse+Galectin-3+Protein/bio_rxiv__2024__02__21__581431-163-0-2 Average 94 stars, based on 1 article reviews
recombinant gal 3 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant galectin ![]() Recombinant Galectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Galectin-3+Recombinant+Protein+Antigen/pmc03603908-49-1-6 Average 93 stars, based on 1 article reviews
recombinant galectin - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
mouse gal3 ![]() Mouse Gal3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Recombinant+Mouse+Galectin-3+Protein%2C+CF/pmc04807496-162-3-8 Average 90 stars, based on 1 article reviews
mouse gal3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
recombinant mouse galectin 3 protein ![]() Recombinant Mouse Galectin 3 Protein, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/lgals3/pmc12757048-78-9-11 Average 86 stars, based on 1 article reviews
recombinant mouse galectin 3 protein - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
r-galectin-3 ![]() R Galectin 3, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/rgalectin+3/10__1161_slash_strokeaha__118__021757-5-3-5 Average 90 stars, based on 1 article reviews
r-galectin-3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
recombinant galectin-3 ![]() Recombinant Galectin 3, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/galectin+3/10__1074_slash_jbc__m114__586461-250-6-20 Average 90 stars, based on 1 article reviews
recombinant galectin-3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
fitc-labelled recombinant galectin-3 ![]() Fitc Labelled Recombinant Galectin 3, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/fluorescently+tagged+galectin+3/pmc06954680-197-0-48 Average 90 stars, based on 1 article reviews
fitc-labelled recombinant galectin-3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
tgf β1 td139 ![]() Tgf β1 Td139, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Recombinant+Human+Transforming+Growth+Factor+%CE%B21/ppr0232456-128-24-30 Average 98 stars, based on 1 article reviews
tgf β1 td139 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
R&D Systems
human galectin 3 antibody ![]() Human Galectin 3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+full+length+galectin-3/Human+Galectin-3+Antibody/pmc07348724-167-17-27 Average 90 stars, based on 1 article reviews
human galectin 3 antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Pediatric research
Article Title: Galectin-3 Expression and Effect of Supplementation in Neonatal Mice with Disseminated Candida albicans Infection
doi: 10.1038/s41390-019-0279-x
Figure Lengend Snippet: Tissue fungal burden and galectin-3 concentrations in adult mice with disseminated candidiasis. Mice (n=7) were infected via tail-vein injection with C. albicans and euthanized at 48 h after injection. Panel A: Tissue fungal burden. Panel B: Mean gal3 concentration in tissue homogenates compared to animals receiving saline (n=10). Error bars represent standard deviation. No differences in tissue gal3 concentration were detected by ANOVA with inter-group comparisons by the Student-Newman-Keuls Method.
Article Snippet: In a subsequent experiment, pups were delivered and randomized to receive 5 μg carrier-free
Techniques: Infection, Injection, Concentration Assay, Saline, Standard Deviation
Journal: Pediatric research
Article Title: Galectin-3 Expression and Effect of Supplementation in Neonatal Mice with Disseminated Candida albicans Infection
doi: 10.1038/s41390-019-0279-x
Figure Lengend Snippet: Tissue fungal burden and galectin-3 concentrations in neonatal mice with disseminated candidiasis. Two-day-old mouse pups (n=14) were infected via intraperitoneal injection with C. albicans and euthanized at 24 h after injection. Panel A: Tissue fungal burden. Panel B: Mean gal3 concentration in tissue homogenates compared to pups receiving saline (n=14). Error bars represent standard deviation. Mean gal3 concentration was reduced in the spleen of infected pups relative to controls based on ANOVA with inter-group comparisons by the Student-Newman-Keuls Method (p=0.04).
Article Snippet: In a subsequent experiment, pups were delivered and randomized to receive 5 μg carrier-free
Techniques: Infection, Injection, Concentration Assay, Saline, Standard Deviation
Journal: Pediatric research
Article Title: Galectin-3 Expression and Effect of Supplementation in Neonatal Mice with Disseminated Candida albicans Infection
doi: 10.1038/s41390-019-0279-x
Figure Lengend Snippet: Survival curve of neonatal mice with disseminated candidiasis after pretreatment with recombinant galectin-3. Two-day-old mouse pups were given intraperitoneal injections of either saline or recombinant gal3, 2 h prior to infection with C. albicans . Uninfected pups receiving gal3 only were included as a control. Pretreatment with gal3 reduced mortality in infected compared to saline treated pups based on log-rank test (p=0.02).
Article Snippet: In a subsequent experiment, pups were delivered and randomized to receive 5 μg carrier-free
Techniques: Recombinant, Saline, Infection, Control
Journal: Pediatric research
Article Title: Galectin-3 Expression and Effect of Supplementation in Neonatal Mice with Disseminated Candida albicans Infection
doi: 10.1038/s41390-019-0279-x
Figure Lengend Snippet: Tissue fungal burden in neonatal mice with disseminated candidiasis pretreated with galectin-3. Two-day-old mouse pups were given intraperitoneal injections of either saline or recombinant gal3, 2 h prior to infection with C. albicans (n=10 pups per group). Tissues were collected at the time of death or at 72 h in surviving animals. Fungal burden is depicted with the bars representing median values. P values were derived based on analysis using a negative binomial model to account for the variability in these data which are not normally distributed.
Article Snippet: In a subsequent experiment, pups were delivered and randomized to receive 5 μg carrier-free
Techniques: Saline, Recombinant, Infection, Derivative Assay
Journal: Pediatric research
Article Title: Galectin-3 Expression and Effect of Supplementation in Neonatal Mice with Disseminated Candida albicans Infection
doi: 10.1038/s41390-019-0279-x
Figure Lengend Snippet: Tissue fungal burden in neonatal mice with disseminated candidiasis at early time points following infection and pretreatment with galectin-3. Two-day-old mouse pups were given intraperitoneal injections of either saline or recombinant gal3, 2 h prior to infection with C. albicans (n=5 pups per group). Pups were euthanized and tissues were collected at 24 and 36 h following infection. Fungal burden is depicted with the bars representing median values. P values were derived based on analysis using a negative binomial model to account for the variability in these data which are not normally distributed. NS – not significant.
Article Snippet: In a subsequent experiment, pups were delivered and randomized to receive 5 μg carrier-free
Techniques: Infection, Saline, Recombinant, Derivative Assay
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: Effects of Trypanosoma cruzi on galectin‐1 and ‐3 in vitro. Recombinant human galectin‐1 (a) or galectin‐3 (b) (2 μg) were incubated with T. cruzi at 37°C for 30 min. After incubation, the mixture was centrifuged and the supernatant filtered before analysis with sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS‐PAGE) and Coomassie blue staining. Proteins observed as result of galectin‐3 and parasite interaction are indicated by arrows. Three proteins of lower molecular weight are designated as bands 1, 2 and 3, as shown. (c) Parasites were fixed with acetone and stained with recombinant galectin‐3–fluorescein isothiocyanate (FITC) in the presence or absence of thiodigalactoside (TGD, 10 mM) prior to image acquisition in a confocal microscope.
Article Snippet:
Techniques: In Vitro, Recombinant, Incubation, Polyacrylamide Gel Electrophoresis, SDS Page, Staining, Molecular Weight, Microscopy
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: Time course of galectin‐3 processing by Trypanosoma cruzi. Galectin‐3 (2 μM) was incubated with parasites for given times and parasite‐free supernatants were subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS‐PAGE) followed by Coomassie blue staining, showing the appearing bands of lower molecular weight, indicated by arrows (bands 1, 2 and 3) (a). Western blot analysis of the proteins found in the supernatant after incubation of galectin‐3 with T. cruzi epimastigotes. Supernatants were run on gradient gels under denaturing conditions. After transfer to nitrocellulose the blotted bands were immunodetected with a specific mouse anti‐human galectin‐3 monoclonal antibody and subsequently visualized with peroxidase‐labelled goat anti‐mouse immunoglobulin (Ig)G antibodies (b). Integrated intensities of intact galectin‐3 and the bands of lower molecular weight (bands 1, 2 and 3) were obtained by densitometric analysis of Coomassie blue staining SDS‐PAGE gel and expressed as percentage of total expression (c).
Article Snippet:
Techniques: Incubation, Polyacrylamide Gel Electrophoresis, SDS Page, Staining, Molecular Weight, Western Blot, Expressing
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: Cleavage sites of galectin‐3 are within the N‐terminal domain. Bands 1, 2 and 3 as referred to previously were isolated and subjected to N‐terminal protein sequencing. Cleavage sites of bands 1, 2, and 3 corresponded to internal sequences of the galectin‐3 protein and are indicated in the peptide sequence shown. Sequences obtained by N‐terminal protein sequencing are underlined. Diagram shows the cleavages sites on a schematic representation of galectin‐3. (a) Bands 1–3 were isolated and matrix‐assisted laser desorption/ionization time of flight (MALDI‐TOF) analysis was conducted to evaluate their molecular weight. Values were compared with the predicted molecular weight based on the galectin‐3 sequence and the N‐terminal sequencing data for each protein (b). Intact galectin‐3 was exposed for 2 h to live parasites, when media were collected, filtered and applied to a lactose‐sepharose column. The column was extensively washed to remove unbound material and eluted with lactose (100 mM) or thiodigalactoside (10 mM). The eluted fraction was further subjected to SDS‐PAGE and stained with Coomasie blue to detect proteins (c).
Article Snippet:
Techniques: Isolation, Sequencing, Molecular Weight, SDS Page, Staining
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: The cleavage of galectin‐3 by Trypanosoma cruzi depends on at least two families of proteases. (a) T. cruzi epimastigotes were treated with phosphatidylinositol‐specific phospholipase C (PI‐PLC) to release glycosylphosphatidylinisotol (GPI)‐anchored proteins to the medium, and galectin‐3 (2 μM) was incubated for 15 min at 37°C with parasites or released supernatants (SN). (b) Galectin‐3 proteolisis by parasites (15 min, 37°C) was conducted in the presence of ortho‐phenanthroline (0·5 and 5 mM), lactose (100 mM) and after heat inactivation of parasites. (c) Galectin‐3 (2 μM) was incubated with parasites at given times (30, 120 and 160 min at 37°C) with OPA, mercuric chloride or the two compounds at the same time. In all cases (a–c), the cleavage of galectin‐3 was analysed by Coomassie blue staining.
Article Snippet:
Techniques: Incubation, Staining
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: Parasites undergo cell death when they are incubated with galectin‐3 in the presence of ortho‐phenanthroline (OPA). Cell viability of Trypanosoma cruzi epimastigotes was evaluated by propidium iodide (PI) staining and flow cytometry. Parasites were incubated (15 min, 37°C) with and without OPA (5 mM), galectin‐1 (2 μM) and parasites killed by heat shock were used as a positive control (90°C, 10 min) for PI staining (a). Neither parasites alone nor OPA‐treated parasites showed a significant increase in PI staining. Galectin‐3 led to parasite killing when it was combined with OPA (5 mM, histogram, dotted line) compared to galectin‐3 without inhibitor (histogram, straight line) or OPA alone (filled grey histogram) (b). Parasites were incubated with increasing concentrations of galectin‐3 in the presence of OPA 5 mM and stained with PI to check cell viability as before. Results show the mean of three independent experiments showing mean and standard error of the mean (s.e.m.). ***P < 0·001, *P < 0·05 compared to non‐treated controls (no galectin‐3, 5 mM OPA) (c).
Article Snippet:
Techniques: Incubation, Staining, Flow Cytometry, Positive Control
Journal: Clinical and Experimental Immunology
Article Title: Trypanosoma cruzi cleaves galectin‐3 N‐terminal domain to suppress its innate microbicidal activity
doi: 10.1111/cei.13379
Figure Lengend Snippet: Galectin‐3 binds non‐pathogenic Trypanosoma rangeli without processing it, resulting in protozoan death. Fluorescein isothiocyanate (FITC)‐labelled recombinant galectin‐3 was incubated with T. rangeli trypomastigotes Choachi (KP1+) and Tre (KP1–) strains at 4°C and galectin binding was quantified by flow cytometry (black histograms) compared to non‐stained cells (straight line) (a), and thiodigalactoside was used (10 mM) to inhibit galectin‐3 binding (grey histogram). Galectin‐3 (2 μg) was incubated with cell‐derived live trypomastigotes of T. cruzi, or in‐vitro differentiated trypomastigotes of T. rangeli at 37°C for 120 min. After incubation, the mixtures were centrifuged and the supernatants filtered, applied to lactose–sepharose, as described previously, analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS‐PAGE) and Coomassie blue staining (b). In‐vitro differentiated trypomastigotes of T. rangeli Choachi were incubated with full‐length galectin‐3 for 10 min at 37°C (white histograms, 5 mM, grey histograms, 20 mM), and then stained with propidium iodide (PI) as described previously to evaluate cell viability compared to non‐treated controls (black histograms) (c).
Article Snippet:
Techniques: Recombinant, Incubation, Binding Assay, Flow Cytometry, Staining, Derivative Assay, In Vitro, Polyacrylamide Gel Electrophoresis, SDS Page